Marshall, Gerstein & Borun LLP

Representative Experience

Dr. Neville has skillfully worked on patent matters in diverse technologies, including:

• Genomics/Proteomics
• Antibody technology
• Growth factors
• Cell adhesion molecules
• Vaccine compositions
• Diagnostic and therapeutic methods
• Recombinant protein production
• Protein purification
• Transgenic animals
• Cell-based therapeutics

Background and Credentials

Dr. Neville has extensively prosecuted domestic and foreign patents, provided due diligence analyses, handled interference, reexamination and opposition proceedings, as well as given non-infringement, patentability, freedom to operate and validity opinions.

She received her J.D. cum laude from The John Marshall Law School. 

Prior to joining the firm, Dr. Neville earned her Ph.D. in 2001 from the Department of Microbiology and Immunology at Northwestern University Medical School.  Her graduate work focused on experimental models of the autoimmune disease Multiple Sclerosis, specifically investigating potential therapeutic methods involved in the regulation of auto-reactive T cell function and their consequent effects on the progression of autoimmune disease.  She received her B.S. in Biochemistry from the University of Notre Dame in 1995.

Publications and Speeches

Dr. Neville has published several articles in peer-reviewed scientific journals and frequently presents CLE seminars on emerging topics in the biotech field, such as recent developments in case law as well as current trends at the US Patent and Trademark Office.

• "Supreme Court hears oral argument on whether isolated DNA is a product of nature — The history and implications of the upcoming AMP. v. Myriad Genetics decision," InsideCounsel, May 7, 2013.
• "Business methods, diagnostics and abstract ideas -- How have Bilski and Mayo impacted claim examination in the PTO?" InsideCounsel, April 23, 2013.
• "Federal Circuit goes all in on double patenting — A recent ruling cautions institutions to monitor the inventorship of assigned patents," InsideCounsel, March 26, 2013.
• "The Notebook, end of a love story? 3 reasons to be diligent with witnessing notebooks post AIA," InsideCounsel, February 23, 2013.

Community and Professional Involvement

• Intellectual Property Law Association of Chicago (IPLAC), Biotech Committee Member
• Association of University Technology Managers (AUTM), member

Representative Matters

Zymogenetics, Inc. v. Kirin Brewery Company, Limited*
U.S. Patent Office Board of Patent Appeals and Interferences
Case Type(s): Patent Interference
Area(s) of practice: Biotechnology

Short Biography